Applied DNA Sciences Inc (APDN)
4.08
+0.08
(+2.00%)
USD |
NASDAQ |
May 01, 16:00
4.16
+0.08
(+1.96%)
After-Hours: 20:00
Applied DNA Sciences Price to Book Value: 0.8319 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 0.8156 |
| April 29, 2024 | 0.785 |
| April 26, 2024 | 0.8911 |
| April 25, 2024 | 1.020 |
| April 24, 2024 | 0.9739 |
| April 23, 2024 | 1.183 |
| April 22, 2024 | 1.346 |
| April 19, 2024 | 1.376 |
| April 18, 2024 | 1.354 |
| April 17, 2024 | 1.336 |
| April 16, 2024 | 1.381 |
| April 15, 2024 | 1.445 |
| April 12, 2024 | 1.520 |
| April 11, 2024 | 1.528 |
| April 10, 2024 | 1.581 |
| April 09, 2024 | 1.574 |
| April 08, 2024 | 1.591 |
| April 05, 2024 | 1.565 |
| April 04, 2024 | 1.605 |
| April 03, 2024 | 1.773 |
| April 02, 2024 | 1.721 |
| April 01, 2024 | 1.685 |
| March 28, 2024 | 1.645 |
| March 27, 2024 | 1.717 |
| March 26, 2024 | 1.748 |
| Date | Value |
|---|---|
| March 25, 2024 | 1.926 |
| March 22, 2024 | 2.002 |
| March 21, 2024 | 2.006 |
| March 20, 2024 | 2.006 |
| March 19, 2024 | 1.791 |
| March 18, 2024 | 1.765 |
| March 15, 2024 | 1.476 |
| March 14, 2024 | 1.492 |
| March 13, 2024 | 1.94 |
| March 12, 2024 | 2.126 |
| March 11, 2024 | 2.126 |
| March 08, 2024 | 2.182 |
| March 07, 2024 | 2.246 |
| March 06, 2024 | 2.254 |
| March 05, 2024 | 2.287 |
| March 04, 2024 | 2.214 |
| March 01, 2024 | 2.246 |
| February 29, 2024 | 2.332 |
| February 28, 2024 | 2.391 |
| February 27, 2024 | 2.375 |
| February 26, 2024 | 2.479 |
| February 23, 2024 | 2.608 |
| February 22, 2024 | 2.638 |
| February 21, 2024 | 2.688 |
| February 20, 2024 | 2.732 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.785
Minimum
Apr 29 2024
16.40
Maximum
Feb 11 2021
3.464
Average
2.510
Median
Oct 20 2023
Price to Book Value Benchmarks
| Fonar Corp | 0.6275 |
| XWELL Inc | 0.5566 |
| ProPhase Labs Inc | 1.882 |
| Veracyte Inc | 1.447 |
| OncoCyte Corp | 1.675 |
Price to Book Value Related Metrics
| PS Ratio | 0.3009 |
| Price | 4.08 |
| Earnings Yield | -269.6% |
| Market Cap | 3.521M |